Dren Bio

company

About

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$65M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$65M
Dren Bio has raised a total of $65M in funding over 2 rounds. Their latest funding was raised on Jun 14, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 14, 2022 Series B $65M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Dren Bio is funded by 1 investors. Pfizer are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Series B